Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment
This study has been terminated.
(This study was stopped after Part 1 completed and was terminated because the predefined criteria of efficacy was not reached ( >50% better then placebo))
First Posted: September 20, 2012
Last Update Posted: April 28, 2016
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )